Literature DB >> 14996416

Resveratrol inhibits phenotypic and functional maturation of murine bone marrow-derived dendritic cells.

Gi-Young Kim1, Hoon Cho, Soon-Cheol Ahn, Yang-Hyo Oh, Chang-Min Lee, Yeong-Min Park.   

Abstract

This study investigated the effects of resveratrol, a natural polyphenol found in grapes and grape products such as wine and having a wide range of biological and pharmacological activities effecting on the phenotypic and functional maturation of bone marrow (BM)-derived dendritic cells (DC). Resveratrol inhibited the expression of costimulatory molecules (CD80 and CD86), and major histocompatibility complex (MHC) classes I and II significantly, and had the same effect dose-dependently on DC. Resveratrol also significantly suppressed the ability of BM-DC to produce intracellular IL-12 p40/p70 and secretory IL-12 p70 in response to lipopolysaccharides (LPS) stimulation. Resveratrol-treated DC were highly efficient in antigen capture via mannose receptor-mediated endocytosis. Also, they were poor stimulators of naïve allogeneic T-cell proliferation and induced lower levels of IL-2 in responding T cells. These results indicate the immunosuppressive properties of resveratrol, which may be therapeutically useful in controlling chronic immune and/or inflammatory diseases through the down-regulation of DC differentiation and maturation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14996416     DOI: 10.1016/j.intimp.2003.12.009

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  12 in total

Review 1.  Are sirtuins viable targets for improving healthspan and lifespan?

Authors:  Joseph A Baur; Zoltan Ungvari; Robin K Minor; David G Le Couteur; Rafael de Cabo
Journal:  Nat Rev Drug Discov       Date:  2012-06-01       Impact factor: 84.694

Review 2.  How tolerogenic dendritic cells induce regulatory T cells.

Authors:  Roberto A Maldonado; Ulrich H von Andrian
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

3.  Lead effects on development and function of bone marrow-derived dendritic cells promote Th2 immune responses.

Authors:  Donghong Gao; Tapan K Mondal; David A Lawrence
Journal:  Toxicol Appl Pharmacol       Date:  2007-04-12       Impact factor: 4.219

4.  GRAS-microparticle microarrays identify dendritic cell tolerogenic marker-inducing formulations.

Authors:  Matthew R Carstens; Clive H Wasserfall; Abhinav P Acharya; Jamal Lewis; Nikunj Agrawal; Kevin Koenders; Evelyn Bracho-Sanchez; Benjamin G Keselowsky
Journal:  Lab Chip       Date:  2021-09-14       Impact factor: 7.517

5.  Resveratrol as a natural anti-tumor necrosis factor-α molecule: implications to dendritic cells and their crosstalk with mesenchymal stromal cells.

Authors:  Andreia M Silva; Marta I Oliveira; Laura Sette; Catarina R Almeida; Maria J Oliveira; Mário A Barbosa; Susana G Santos
Journal:  PLoS One       Date:  2014-03-10       Impact factor: 3.240

Review 6.  Metabolic control of dendritic cell activation and function: recent advances and clinical implications.

Authors:  Bart Everts; Edward J Pearce
Journal:  Front Immunol       Date:  2014-05-08       Impact factor: 7.561

7.  Nanostructured lipid carriers loaded with resveratrol modulate human dendritic cells.

Authors:  João P Barbosa; Ana R Neves; Andreia M Silva; Mário A Barbosa; M Salette Reis; Susana G Santos
Journal:  Int J Nanomedicine       Date:  2016-07-28

8.  Defined Small Molecules Produced by Himalayan Medicinal Plants Display Immunomodulatory Properties.

Authors:  Phurpa Wangchuk; Simon H Apte; Michael J Smout; Penny L Groves; Alex Loukas; Denise L Doolan
Journal:  Int J Mol Sci       Date:  2018-11-06       Impact factor: 5.923

Review 9.  Modulation of dendritic cell immune functions by plant components.

Authors:  Alia M Aldahlawi
Journal:  J Microsc Ultrastruct       Date:  2016-01-08

10.  Resveratrol regulates naïve CD 8+ T-cell proliferation by upregulating IFN-γ-induced tryptophanyl-tRNA synthetase expression.

Authors:  Kyung Tae Noh; Joon Cho; Sung Hak Chun; Jong-Hwa Jang; Gil Sun Cha; In Duk Jung; Dong Deuk Jang; Yeong-Min Park
Journal:  BMB Rep       Date:  2015-05       Impact factor: 4.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.